Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Transcode Therapeutics, Inc. | 650,000 | reported | 14 Jun 2024 | tx 7+1,196,350 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Jun 2024 | GRANT_AWARD | Transcode Therapeutics, Inc. | 650,000 | 0.00 USD | deriv |
| 28 Sept 2023 | PURCHASE | Transcode Therapeutics, Inc. | 49,350 | 0.51 USD | first after silence |
| 19 May 2023 | GRANT_AWARD | Transcode Therapeutics, Inc. | 300,000 | 0.00 USD | deriv |
| 12 Dec 2022 | GRANT_AWARD | Transcode Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 16 Jun 2022 | PURCHASE | Transcode Therapeutics, Inc. | 12,000 | 1.27 USD | |
| 01 Mar 2022 | GRANT_AWARD | Transcode Therapeutics, Inc. | 52,000 | 0.00 USD | deriv |
| 01 Feb 2022 | GRANT_AWARD | Transcode Therapeutics, Inc. | 33,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 28 Sept 2023.